So much has happened since the petition against the ABIM MOC started on 7/21/2023, which is nearing 20,000 signatures. Physicians have called upon their societies and organizations to offer statements on their behalf, but only The Society for Cardiovascular Angiography & Interventions (SCAI) so far has done so. Drs. Srihari Naidu and Allison Dupont, both members and leaders of SCAI, come on the show to explain why they came up with the statement and what it means to the membership. Is there a path forward and why have other societies stayed silent thus far? Drs. Naidu and Allison Dupont offer refreshing opinions as to what might get done and what is to come after the praise that SCAI received.
Learn more about the SCAI: https://scai.org/
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
